Chios Mastic Fractions in Experimental Colitis: Implication of the Nuclear Factor κb Pathway in Cultured HT29 Cells

Journal of Medicinal Food

Volumn 15, Issue 11, 2012, Pages 974-983

  Papalois, Apostolos ^a   Gioxari, Aristea ^b   Kaliora, Andriana C ^b   Lymperopoulou, Aikaterini ^b   Agrogiannis, George ^c   Papada, Efstathia ^b   Andrikopoulos, Nikolaos K ^b  

^a ELPEN Pharmaceuticals Co Inc   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

cytokine expression; inflammatory bowel disease; lactate dehydrogenase; nuclear factor B p65; Pistacia lentiscus

Indexed keywords

CHIOS MASTIC; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; OLEANOLIC ACID; PLANT RESIN; TRANSCRIPTION FACTOR RELA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HT29; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; ENZYME RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; COLON; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; HT29 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NF-KAPPA B; PISTACIA; PLANT EXTRACTS; RATS; RATS, WISTAR; RESINS, PLANT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

PISTACIA LENTISCUS; RATTUS;

EID: 84868517662     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0018     Document Type: Article

References (31)

1. Kaliora AC, Kountouri AM: Chemopreventive activity of Mediterranean medicinal plants. In: Cancer Prevention-From Mechanisms to Translational Benefits (Georgakilas A, ed.). InTech, Rijeka, Croatia, 2012, pp. 261-284.
2. Al-Habbal MJ, Al-Habbal Z, Huwez FU: A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol 1984;11:541-544.
3. Al-Said MS, Ageel AM, Parmar NS, Tarig M: Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol 1986;15:271-278.
4. Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papa-peorgiou VP: Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation. Phytother Res 2003;17:501-507.
5. Dedoussis GV, Kaliora AC, Psarras S, Chiou A, Mylona A, Papadopoulos NG, Andrikopoulos NK: Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis 2004;174:293-303.
6. Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D, Skaltsounis AL: In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother 2007;51:551-559.
7. Dimas K, Hatziantoniou S, Wyche JH, Pantazis P: A mastic gum extract induces suppression of growth of human colorectal tumor xenografts in immunodeficient mice. In Vivo 2009;23:63-68.
8. Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK: Chios mastic treatment of patients with active Crohn's disease. World J Gastroenterol 2007;13:748-753.
9. Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK: Alternations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic. World J Gastroenterol 2007;13:6031-6036.
10. Gioxari A, Kaliora AC, Papalois A, Agrogiannis G, Trianta-fillidis JK, Andrikopoulos NK: Pistacia lentiscus resin regulates intestinal damage and inflammation in trinitrobenzene sulfonic acid-induced colitis. J Med Food 2011;14:1403-1411.
11. Papageorgiou VP, Bakola-Christianopoulou MN, Apazidou KK, Psarros EE: Gas chromatographic-mass spectroscopic analysis of the acidic triterpenic fraction of mastic gum. J Chromatogr A 1997;769:263-273.
12. Juan ME, Wenzel U, Ruiz-Gutierrez V, Daniel H, Planas JM: Olive fruit extracts inhibit proliferation and induce apoptosis in HT-29 human colon cancer cells. J Nutr 2006;136:2553-2557.
13. Senthil S, Sridevi M, Pugalendi KV: Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol 2007;35:418-423.
14. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533.
15. Sanchez-Muñoz F, Dominguez-Lopez A, Yamamoto-Furusho JK: Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008;14:4280-288.
16. Kalogeropoulos N, Chiou A, Ioannou M, Karathanos VT, Hassapidou M, Andrikopoulos NK: Nutritional evaluation and bioactive microconstituents (phytosterols, tocopherols, polyphenols, triterpenic acids) in cooked dry legumes usually consumed in the Mediterranean countries. Food Chem 2010;121:682-690.
17. Triantafillidis JK, Papalois AE, Parasi A, Anagnostakis E, Burnazos S, Gikas A, Merikas EG, Douzinas E, Karagianni M, Sotiriou H: Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastro-enterol 2005;11:6843-6847.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. Lubbad AS, Oriowo MA, Khan I: Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis. Scand J Gastroenterol 2009;44:187-194.
20. Siani AC, Ramos MF, Menezes-de-Lima O Jr, Ribeiro-dos-Santos R, Fernadez-Ferreira E, Soares RO, Rosas EC, Susunaga GS, Guimarães AC, Zoghbi MG, Henriques MG: Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. J Ethnopharmacol 1999; 66:57-69.
21. Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB: Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha-and beta-amyrin, in a mouse model of colitis. Br J Pharmacol 2009;157:1034-1044.
22. Sun Y, Cai TT, Shen Y, Zhou XB, Chen T, Xu Q: Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance. Int Immunopharmacol 2009;9:1437-1443.
23. Isik F, Tunali Akbay T, Yarat A, Genc Z, Pisiriciler R, Caliskan-Ak E, Cetinel S, Altintas A, Sener G: Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats. Dig Dis Sci 2011;56:721-730.
24. Casellas F, Borruel N, Torrejón A, Varela E, Antolin M, Guarner F, Malagelada JR: Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007;25:1061-1067.
25. Ito H, Tanabe H, Kawagishi H, Tadashi W, Yasuhiko T, Sugiyama K, Kiriyama S, Morita T: Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats. Dig Dis Sci 2009;54:2100-2108.
26. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Ray-ment N, Kamm MA, Knight SC, Forbes A: Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006;55:348-355.
27. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
28. Kamada N, Hisamatsu T, Okamoto S, Sato T, Matsuoka K, Arai K, Nakai T, Hasegawa A, Inoue N, Watanabe N, Akagawa KS, Hibi T: Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 2005;175:6900-6908.
29. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS: Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem 2000; 275:32681-32687.
30. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Schölmerich J, Gross V: Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998;115:357-369.
31. Sung M, Kendall C, Koo M, Rao A: Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture. Nutr Cancer 1995;23:259-269.